ACM
ABBV icon

Absolute Capital Management’s AbbVie ABBV Stock Holding History

Absolute Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,158
Closed -$265K – 147
2025
Q4 		$265K Buy
1,158
+181
+19% +$41.2K 0.1% 113
2025
Q3 		$226K Buy
+977
New +$199K 0.1% 114
2022
Q4 		– Sell
-136
Closed -$18.9K – 74
2022
Q3 		$18.9K Buy
+136
New +$19.5K 0.02% 140
2022
Q1 		– Sell
-56
Closed -$7.58K – 56
2021
Q4 		$7.58K Buy
+56
New +$6.62K 0.01% 209

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Absolute Capital Management's ABBV Position: Q1 2026 in Review

Absolute Capital Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,158 shares — an estimated $265K sold.

Absolute Capital Management first reported a position in ABBV in Q4 2021 and held it in 4 quarters. The position peaked at $265K in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Absolute Capital Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Absolute Capital Management sold 1,158 AbbVie shares in Q1 2026, an estimated $265K.
  • Absolute Capital Management first reported a position in AbbVie in Q4 2021 and held it in 4 quarters.
  • Absolute Capital Management's AbbVie position peaked at $265K in Q4 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Absolute Capital Management's 13F filing for Q1 2026, filed 12 May 2026.